Cardiovascular health remains a global concern, and one of the reasons that consumers seek protective benefits of dietary supplementation. As much as 80% of consumers in Europe and the US recognize the link between good heart health and good overall health (FMCG).
In recent years, there has been a strong focus on the role of arterial stiffness impacting cardiovascular health, as well as the discovery of the vitamin K-dependent protein Matrix Gla Protein (MGP).
MGP is the most potent modulator of vascular calcification known, provided the body has enough Vitamin K2 to activate it.
MenaQ7® is the only clinically proven Vitamin K2 as MK7 for cardiovascular health with groundbreaking studies. The 3-year study showed a nutritional dose of MenaQ7® taken daily not only inhibited age-related arterial stiffening, but also promoted vascular elasticity.
Choose MenaQ7® to support your heart health claims with science!
Latest news & videos
- News
- Quatrefolic®
- Reproduction & Women
- Sep 20, 2024
New Quatrefolic® Educational Videos: MTHFR Polymorphism
Approximately half of the global population may carry some form of MTHFR mutation. MTHFR...
- MenaQ7®
- Mobility & Joint
- News
- Sep 18, 2024
Unlock the Benefits of Fortified Dairy with MenaQ7® Vitamin K2
The growing consumer interest in fortified foods presents dairy brands with a prime opportunity...
- Download
- Lynside® Nutritional Yeasts
- News
- Sep 16, 2024
Discover All The Benefits Of Zinc
On Nutricosmetics
Consumers are becoming increasingly aware of the benefits of nutrition for beauty, which is...
